January 2012
03.01 ONSOLIS To Benefit From Approval Of Class-Wide REMS For All Transmucosal Fentanyl Products
03.01 FDA To Approve Shared System REMS For TIRF Products
01.01 TriReme Medical, Inc. Receives FDA 510(K) Clearance For Chocolate PTA Balloon Catheter
01.01 VIVUS Announces Date Of FDA Advisory Committee Review Of Qnexa For The Treatment Of Obesity
Pages 1 2